SCHEMBL14133169

SCHEMBL14133169

[18F]CCc1ccc2c(c1)[nH]c1ccncc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 3/20 0.56
▸ ACHE P22303 4/20 0.51
▸ MAPT P10636 7/20 0.51
▸ CHUK O15111 3/20 0.42
▸ HTR6 P50406 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ GABRP O00591 1/20 0.40
▸ GABRD O14764 1/20 0.40
▸ IKBKB O14920 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ TOP1 P11387 1/20 0.40
▸ GABRA1 P14867 1/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRG2 P18507 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14053792 1.00 KIF11 (0.56) KIF11ACHEMAPTCHUKHTR6
SCHEMBL14133908 0.91 KIF11 (0.54) KIF11ACHEMAPTCHUKHTR6
SCHEMBL14053477 0.91 KIF11 (0.54) KIF11ACHEMAPTCHUKHTR6
SCHEMBL14053621 0.86 KIF11 (0.49) KIF11ACHEMAPTCHUKHTR6
SCHEMBL20652671 0.81 ACHE (0.51) KIF11ACHEMAPTCHUKKDM4E
SCHEMBL14054064 0.81 KIF11 (0.49) KIF11ACHEMAPTCHUKKDM4E
SCHEMBL23391734 0.80 TBXAS1 (0.52) KIF11ACHEMAPTKDM4EALDH1A1
SCHEMBL31104422 0.80 TBXAS1 (0.52) KIF11ACHEMAPTKDM4EALDH1A1
SCHEMBL14133180 0.79 KIF11 (0.47) KIF11ACHEMAPTCHUKPARP1
SCHEMBL20652942 0.79 KDM4E (0.50) KIF11ACHEMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120302755-A1 Imaging Agents for Detecting Neurological Dysfunction SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2012-11-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120302755-A1 Imaging Agents for Detecting Neurological Dysfunction SLC18A3, TSPO, CHAT KIF11 3323/4885ACHE 5/4885MAPT 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback